Wild orchid and gardenia contain antioxidants to reduce fine lines and improve the overall appearance of skin with natural, fortified minerals
Tirzepatide is a dual agonist that combines: GLP-1 (glucagon-like peptide-1) activity GIP (glucose-dependent insulinotropic polypeptide) activity This combination creates a stronger incretin effect, improving insulin sensitivity and appetite control more effectively than GLP-1 medications alone
The body composition benefits of the stack become clearly visible
The addition of GIP receptor activation, combined with powerful GLP-1 action, slows down stomach emptying and intestinal transit more profoundly than single-agonist medications, giving food and gas significantly more time to linger and ferment
DermaVue recommends Mounjaro as first-line for most patients, with semaglutide reserved for those with specific clinical indications, budget constraints, or thin-fat phenotype without significant insulin resistance